COVID-19 & ACE-inhibitors or ARBs

NICE has published COVID-19 rapid evidence summary: angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or […]

Northern England Clinical Network NOAC Alert Cards – Supplies

Northern England Clinical Network (NECN) Non-Vitamin K Oral Anticoagulant medicines (NOAC) Alert Cards In 2015, NECN Cardiac Rhythm Management subgroup […]

AHSN Atrial Fibrillation Card Deck_2018 Refresh

The Academic Health Science Network for the North East & North Cumbria have refreshed the Anticoagulant Treatment in Atrial Fibrillation […]

CCG Briefing on Sacubitril Valsartan (Entresto®) NICE Technology Appraisal Guidance TA388

This briefing is designed to inform CCGs of the implications of NICE TAG 388 Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction.